Submitted by Anonymous (not verified) on 21 August 2026 - 14:02
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 40, Status: Authorised